SAN DIEGO, CA -- (MARKET WIRE) -- April 04, 2007 -- Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present its recently formed Cedar Therapeutics Inc. spin-out company at the C21 BioVentures Conference to be held at the Monterey Plaza Hotel and Spa, Monterey, CA May 22-24, 2007. Cedar Therapeutics was formed to develop novel, proprietary, and superior formulations for certain drugs recently or soon-to-be off-patent addressing a current total market in excess of $11 Billion and eligible for FDA 505(b)2 accelerated regulatory treatment using Aegis’ proprietary Intravail® and ProTek® advanced proprietary drug delivery and formulation technologies.
